{"title":"The Effects of Nafamostat Mesilate on a Bleeding Risk as an Anticoagulant During Use as a Continuous Renal Replacement Therapy: Systematic Review","authors":"강혜영, 강영주, 문수지","doi":"10.34161/JOHTA.2018.6.2.008","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":305839,"journal":{"name":"The Journal of Health Technology Assessment","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2018-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Journal of Health Technology Assessment","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.34161/JOHTA.2018.6.2.008","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}